Zinc and Copper Homeostasis in Head and Neck Cancer: Review and Meta-Analysis
Journal:
Current Medicinal Chemistry
Volume:
23
Page:
1304-1330
Author(s):
Alzbeta Ressnerova, Martina Raudenska, Monika Holubova, Marketa Svobodova, Hana Polanska, Petr Babula, Michal Masarik and Jaromir Gumulec
Non-Photoinduced Biological Properties of Verteporfin
Journal:
Current Medicinal Chemistry
Volume:
23
Page:
1171-1184
Author(s):
Floriane Gibault, Matthieu Corvaisier, Fabrice Bailly, Guillemette Huet, Patricia Melnyk and Philippe Cotelle
Predictive Efficacy Biomarkers of Programmed Cell Death 1/Programmed Cell Death 1 Ligand Blockade Therapy
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
11
Page:
141-151
Author(s):
Xiao-Na Fang and Li-Wu Fu
Metal Containing Cytostatics and Their Interaction with Cellular Thiol Compounds Causing Chemoresistance
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
16
Page:
686-698
Author(s):
Jan Hrabeta, Vojtech Adam, Tomas Eckschlager, Eva Frei, Marie Stiborova and Rene Kizek
Emerging Immunotargets in Bladder Cancer
Journal:
Current Drug Targets
Volume:
17
Page:
757-770
Author(s):
Francesco Massari, Chiara Ciccarese, Nuno Vau, Matteo Santoni, Rodolfo Montironi, Liang Cheng, Rita C. Marques, Marina Scarpelli, Jorge Fonseca, Marc R Matrana, Moch Holger, Stefano Cascinu, Giampaolo Tortora and Antonio Lopez-Beltran
Emerging Immunotargets in Metastatic Renal Cell Carcinoma
Journal:
Current Drug Targets
Volume:
17
Page:
771-776
Author(s):
John Kucharczyk, Marc R. Matrana, Matteo Santoni, Francesco Massari, Marina Scarpelli, Liang Cheng, Antonio Lopez-Beltran, Stefano Cascinu, Rodolfo Montironi and Moch Holger
Molecular Pharmacology of Malignant Pleural Mesothelioma: Challenges and Perspectives From Preclinical and Clinical Studies
Journal:
Current Drug Targets
Volume:
17
Page:
824-849
Author(s):
Stefano Thellung, Roberto E. Favoni, Roberto Würth, Mario Nizzari, Alessandra Pattarozzi, Antonio Daga, Tullio Florio and Federica Barbieri
An Overview of Emerging Immunotargets of Genitourinary Tumors
Journal:
Current Drug Targets
Volume:
17
Page:
750-756
Author(s):
Rodolfo Montironi, Matteo Santoni, Liang Cheng, Antonio Lopez-Beltran, Francesco Massari, Marc R. Matrana, Holger Moch and Marina Scarpelli
Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin
Journal:
Current Cancer Drug Targets
Volume:
16
Page:
288-304
Author(s):
Zhipeng Zou, Juan Chen, Jun Yang and Xiaochun Bai
Anti-Angiogenic Therapy: Strategies to Develop Potent VEGFR-2 Tyrosine Kinase Inhibitors and Future Prospect
Journal:
Current Medicinal Chemistry
Volume:
23
Page:
1000-1040
Author(s):
Leilei Shi, Jianfeng Zhou, Jifeng Wu, Yuemao Shen and Xun Li